$38.47
arrow_drop_down3.46%Key Stats | |
---|---|
Open | $39.71 |
Prev. Close | $39.85 |
EPS | -2.73 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 38.47 | 40.03 |
52 Week Range | 27.98 | 50.99 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -2.73 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag
Xenon Pharmaceuticals Presents Data from Phase 2 X-NOVA Clinical Trial of Azetukalner in Major Depressive Disorder at the American Society of Clinical Psychopharmacology 2024 Annual Meeting
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
Xenon Pharmaceuticals to Present at the BofA Securities Health Care Conference 2024
Xenon Pharmaceuticals to Present at the 2024 RBC Capital Markets Global Healthcare Conference